ARLZ Aralez Pharmaceuticals Inc.

1.54
-0.06  -4%
Previous Close 1.60
Open 1.59
Price To book 1.38
Market Cap 101425561
Shares 65,860,754
Volume 525,799
Short Ratio 3.66
Av. Daily Volume 851,472

SEC filingsSee all SEC filings

  1. CT ORDER - Confidential treatment order 171080820
  2. 10-Q - Quarterly report [Sections 13 or 15(d)] 171018011
  3. 8-K - Current report 171016422
  4. 8-K - Current report 17931140
  5. CT ORDER - Confidential treatment order 17920451

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approved April 30, 2010.
VIMOVO
Gastric ulcers
Approval announced September 15, 2016.
YOSPRALA (PA32540/PA8140)
Secondary prevention of cardiovascular disease in patients at risk for aspirin-induced gastric ulcers

SEC Filings

  1. CT ORDER - Confidential treatment order 171080820
  2. 10-Q - Quarterly report [Sections 13 or 15(d)] 171018011
  3. 8-K - Current report 171016422
  4. 8-K - Current report 17931140
  5. CT ORDER - Confidential treatment order 17920451
  6. 8-K - Current report 17897162
  7. 8-K - Current report 17895568
  8. 8-K - Current report 17895527
  9. 8-K - Current report 17839970
  10. 10-Q - Quarterly report [Sections 13 or 15(d)] 17827293